SunPharma Buyback: The company was first established in 1982 as a joint venture with M/s Sun Pharmaceutical Industries and was subsequently registered as a joint-stock company (public limited company) on 1 March 1993 under the provisions of Part IX of Companies Act, 1956. The Company issued a Business Certificate dated 18 March 1993.
Sun Pharma is the world’s largest specialty generic pharmaceutical company (Source – Evolution Pharma) and India’s top pharmaceutical company (Source – AIOCD AWACS). The vertically integrated business and expertise team enables us to deliver high-quality products trusted by customers and patients at affordable prices in more than 100 countries around the world. The company’s global footprint spans North America, Western Europe, Japan, Australia, and New Zealand, Israel, and 80 emerging markets.
Sun Pharma Board today approved the buyback of 1,700 crore shares at a rate of Rs. 425 per share. Sun Pharma stated that at the maximum buy-back size and maximum buy-back price, the maximum equity shares to be buyback under the buy-back represents 1.67% of the company’s equity shares. Sun Pharma said the buyback offer process, timelines, and other required details will be issued in due course as per the terms of the buy-back regulations.
In this article, we will discuss Sun Pharmaceutical Industries Limited Buyback offer, buyback price, buyback size, Sun Pharmaceutical Industries Buyback record date, company financial.
SunPharma Buyback Details
|Buyback Type||Open Market|
|Opening Date||March 26, 2020|
|Closing Date||September 25, 2020|
|Buyback Offer Amount||Rs.1700,00,00,000|
|Buyback No. of Shares||4,00,00,000|
|Date of Buyback Approval||March 17, 2020|
|Date of Public Announcement||March 19, 2020|
|Buy Back Price||Rs.425/-|
|Buy Back Premium||1.74%|
|Date of Board Meeting||March 17, 2020|
SunPharma Buyback Acceptance Ratio
Find profit & profit percentage based on various acceptance rate, The profit is calculated based on 1000 shares.
|Acceptance Ratio||Total Shares Accepted||Buyback Price||Buyback Amount||Profit||Profit%|
SunPharma – Manager to the Buyback
|Vivro Financial Services Private Limited|
607, 608 Marathon Icon, Opp. Peninsula Corporate Park,
Off Ganpatrao Kadam Marg, Veer Santaji Lane, Lower Parel, Mumbai – 400 013, Maharashtra, India
|Contact Person: Mr. Harish Patel / Mr. Bhargav Parekh|
Email: firstname.lastname@example.org | Website: www.vivro.net
Tel: +91 22 6666 8040/41/42 | Fax: +91 22 6666 8047
SEBI Registration Number: INM000010122 | Validity: Permanent |
Sun Pharma – Registrar to the Buyback
|Link Intime India Private Limited|
Address: C 101, 247 Park, L.B.S.Marg, Vikhroli (West),
Mumbai – 400083, Maharashtra, India.
Telephone: 022 – 4918 6270/022 – 4918 6200
Email ID: email@example.com/ firstname.lastname@example.org
Contact Person: Ms. Jiny Elizabeth | SEBI Registration Number: INR000004058
Validity: Permanent. CIN: U67190MH1999PTC118368
Sun Pharma – Contact Details for BuyBack Offer
|Sun Pharmaceutical Industries Limited|
Corporate Identification Number: L24230GJ1993PLC019050
Registered Office: Sun Pharma Advanced Research Centre(SPARC), Tandalja,
Vadodara – 390 012, Gujarat, India.
|Corporate Office: SUN House, CTS No. 201 B/1, Western Express Highway,Goregaon (E),|
Mumbai – 400063, Maharashtra, India.
Phone: +91 22 4324 4324 | Fax: +91 22 4324 4343
E-mail ID: email@example.com| Website: www.sunpharma.com
Contact Persons: Mr. Ashok I Bhuta (Compliance Officer) | Mr. Sunil Ajmera (Company Secretary & Compliance Officer)
List of BuyBack of Shares 2020
- Granules India BuyBack
- Indiabulls Real Estate BuyBack
- Emami BuyBack
- Sterlite Technologies BuyBack Offer